Stay updated on Clinical Trial: Diabetes & Cardiovascular Events Weekly Incretin
Sign up to get notified when there's something new on the Clinical Trial: Diabetes & Cardiovascular Events Weekly Incretin page.

Latest updates to the Clinical Trial: Diabetes & Cardiovascular Events Weekly Incretin page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a clinical trial assessing dulaglutide's effects on cardiovascular events in type 2 diabetes patients, including inclusion and exclusion criteria. Additionally, the version number has been updated from v2.14.4 to v2.15.0.SummaryDifference2%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check41 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check64 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.2%
- Check90 days agoChange DetectedThe web page has been updated to reflect a new version (v2.14.2) of the NLM-NCBI services and products, which are currently experiencing heavy traffic that may impact performance and availability.SummaryDifference0.2%
Stay in the know with updates to Clinical Trial: Diabetes & Cardiovascular Events Weekly Incretin
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Diabetes & Cardiovascular Events Weekly Incretin page.